← К результатам

Int J Mol Sci · 2024

CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans.

International journal of molecular sciences, 25(10) PMID 38791336 DOI 10.3390/ijms25105292

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

Harnessing of CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated genes) systems for detection, chemical modification, and sequence editing of nucleic acids dramatically changed many fields of fundamental science, biotechnology, and biomedicine [...].

Цитирование